Therapeutic efficacy of macrolides in management of patients with mild COVID-19

Therapeutic efficacy of macrolides in management of patients with mild COVID-19

Abstract Evidence on the efficacy of adding macrolides (azithromycin or clarithromycin) to the treatment regimen for COVID-19 is limited. We testify whether adding azithromycin or clarithromycin to a standard of care regimen was superior to standard of supportive care alone in patients with mild COV...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alaa Rashad, Asmaa Nafady, Mohammed H. Hassan, Haggagy Mansour, Usama Taya, Shamardan Ezzeldin S. Bazeed, Zaki F. Aref, Mennatallah Ali Abdelrhman Sayed, Hanaa Nafady-Hego, Aida A. Abdelmaksoud
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/3ec6355f17034a7da6b25ea25f3716d9
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/3ec6355f17034a7da6b25ea25f3716d9

Ejemplares similares